Literature DB >> 7297926

Treatment of chronic erosive gastritis with prednisolone.

M J Farthing, P D Fairclough, J E Hegarty, E T Swarbrick, A M Dawson.   

Abstract

Short-term oral prednisolone was successfully used in the treatment of four patients with chronic erosive gastritis which had failed to respond to conventional therapies. Symptomatic improvement occurred in all patients during the first week of treatment. Gastroduodenoscopy after two weeks showed that the erosions had healed. Remission has continued in these four patients for two, seven, eight, and nine months without maintenance therapy. This limited uncontrolled study suggests the corticosteroids may be of benefit in patients with chronic erosive gastritis who fail to respond to conventional treatment.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7297926      PMCID: PMC1419870          DOI: 10.1136/gut.22.9.759

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  4 in total

1.  Erosive gastritis; clinical review and analysis of twenty-seven cases.

Authors:  L WALK
Journal:  Gastroenterologia       Date:  1955

2.  Letter: Gastritis varioliformis, allergy, and disodium cromoglycate.

Authors:  C André; B Moulinier; R Lambert; B Bugnon
Journal:  Lancet       Date:  1976-05-01       Impact factor: 79.321

Review 3.  Idiopathic chronic gastritis.

Authors:  D Chatterjee
Journal:  Surg Gynecol Obstet       Date:  1976-12

4.  Diffuse varioliform gastritis.

Authors:  R Lambert; C André; B Moulinier; B Bugnon
Journal:  Digestion       Date:  1978       Impact factor: 3.216

  4 in total
  2 in total

1.  Chronic erosive gastritis--a recently recognized disorder.

Authors:  G H Elta; K A Fawaz; Y Dayal; A M McLean; E Philipps; S M Bloom; R E Paul; M M Kaplan
Journal:  Dig Dis Sci       Date:  1983-01       Impact factor: 3.199

2.  Neoplasia in chronic erosive (varioliform) gastritis.

Authors:  M S Cappell; P H Green; C Marboe
Journal:  Dig Dis Sci       Date:  1988-08       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.